When we see a study showing that an ingredient increased GLP-1 levels by a certain percentage, its tempting to connect that directly to weight loss, says Dr
How can I transition a patient from Zepbound (tirzepatide) to retatrutide, specifying the washout period, starting dose, titration schedule, monitoring (weight, fasting glucose/HbA1c, blood pressure, renal function, gastrointestinal side effects) and contraindications (medullary thyroid carcinoma, multiple endocrine neoplasia type 2)?
Patients with certain GLP1R variants may experience more pronounced appetite suppression or higher nausea sensitivity, helping your PlexusDx provider personalize both your dose escalation and dietary recommendations for your unique biology
So you learn all that throughout the book
"Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity." OASIS 4 trial: 16.6% mean weight loss with treatment adherence
It can only be accessed through regulated clinical trials